Max Planck Institute

nCas9-deaminase crystallography, thermostable deaminases.

Country
Germany
Coverage
CNEUINUS
biofuels-bioenergy✓✓✓✓
ecosystem-restoration✓✓—✓
genome-engineering✓✓—✓
Regulatorsusda-aphisepaneaefsamoa-chinafdaemanmpa

Verifiable facts

FactValueSource
AffiliationMax Planck Society for the Advancement of Sciencebiochem.mpg.de
Research focusBiochemistry, structural biology, cell biology, and genome editing technologies including high-precision base editors and nucleobase deaminasesdoi.org · biochem.mpg.de · max-planck-innovation.de · mpg.de
FacilityCrystallization Facility (MPI of Biochemistry and MPI for Multidisciplinary Sciences)biochem.mpg.de · mpinat.mpg.de
Headcount750 employees (Max Planck Institute of Biochemistry)biochem.mpg.de
Principal staffScientific directors and research group leaders (e.g., Karsten Borgwardt, Franz-Ulrich Hartl, Matthias Mann, Brenda A. Schulman, Petra Schwille, Kikuë Tachibana)biochem.mpg.de · mpg.de
PublicationsResearch published in journals such as Nature Communications and Nature Biotechnology regarding Cas9-deaminase fusion proteins and base editing precisiondoi.org · max-planck-innovation.de

Independent sources: biochem.mpg.de · doi.org · max-planck-innovation.de · mpg.de · mpinat.mpg.de

Technologies
NameClusterRisk
Base editinggenome-engineeringMedium→
Biodiversity genomicsecosystem-restorationLow→
Engineered photosynthesis and artificial chloroplastsbiofuels-bioenergyMedium→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.